Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

10.41

+0.80 (8.32%)

At close: Aug 7, 2026, 4:00 PM EDT

10.42

+0.01 (0.10%)

After-hours: Aug 7, 2026, 6:29 PM EDT

Turn Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-6.72	-5.86	-1.8	-2.31
Net Income	-3.84	-3.19	-1.77	-2.29
Earnings Per Share	-0.14	-0.12	-0.07	-0.12
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	11.22	5.08	0.87	1.18
Total Debt	6.01	0.08	0.12	0.03
Net Cash (Debt)	5.21	5	0.75	1.16
Net Cash Growth	593.47%	564.72%	-34.98%	-
Net Cash Per Share	0.18	0.18	0.03	0.04

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-3.79	-2.56	-1.36	-1.38
Free Cash Flow	-3.79	-2.56	-1.36	-1.38
Free Cash Flow Growth	-	-	-	-

Valuation

Selected indicators aren't available for this stock.